Correlation of Electrophysiology with Pathology, Pathogenesis, and Anticholinesterase Therapy in Post‐Polio Syndrome

Annals of the New York Academy of Sciences

Volumn 753, Issue 1, 1995, Pages 138-150

  CASHMAN, NEIL R ^a   TROJAN, DARIA A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; EDROPHONIUM; PYRIDOSTIGMINE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FATIGUE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL ASSESSMENT; MOTOR UNIT; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE DENERVATION; MUSCLE REINNERVATION; NEUROMUSCULAR SYNAPSE; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PATHOLOGY; POLIOMYELITIS; POSTPOLIOMYELITIS SYNDROME; SINGLE BLIND PROCEDURE;

EID: 0029077243     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1995.tb27540.x     Document Type: Article

References (54)

1. Sur un cas de paralysie générale spinale antérieure subaigue, suivi d'autopsie
2. Paralysie essentielle de 1'enfance: atrophie musculaire consécutive
3. Poliomyelitis in Rochester, Minnesota, 1935–1955: Epidemiology and long‐term sequelae. A preliminary report
4. Late effects of poliomyelitis: A national survey
5. Neurologic manifestations of the post‐polio syndrome
6. Late effects of paralytic poliomyelitis in Olmsted County, Minnesota
7. Postpoliomyelitis: New problems with an old disease
8. New muscle atrophy as a late symptom of the post‐poliomyelitis syndrome
9. A long‐term follow‐up study of patients with post‐poliomyelitis neuromuscular symptoms
10. Occurrence of post‐polio sequelae in an epidemic population
11. Late sequelae of paralytic poliomyelitis in Olmsted County, Minnesota
12. Predictive factors for post‐poliomyelitis syndrome
13. Functional recovery: A major risk factor for development of postpoliomyelitis muscular atrophy
14. Changes in spinal cord motor neurons of possible relevance to the late effects of poliomyelitis
15. The number of limb motor neurons in the human lumbosacral cord throughout life
16. Late changes in the motor unit after acute poliomyelitis
17. New concepts of the reinnervated motor unit revealed by vaccine‐associated poliomyelitis
18. Electrophysiology and electrodiagnosis of the post‐polio motor unit
19. Late denervation in patients with antecedent paralytic poliomyelitis
20. Electromyographical studies of free autogenous muscle transplants in man
21. Neural cell adhesion molecule (N‐CAM) accumulates in denervated and paralyzed skeletal muscles
22. Neural cell adhesion molecule in normal, denervated, and myopathic human muscle
23. Neuromuscular transmission as a function of motor unit size in patients with prior poliomyelitis
24. Macro EMG
25. Pathophysiology and late changes of the motor unit after poliomyelitis
26. Postpolio muscular atrophy: Diagnostic utility of macroelectromyogrpahy
27. Macroelectromyography and fiber density in post‐poliomyelitis syndrome
28. Electromyographic study of defects of neuromuscular transmission in human poliomyelitis
29. Axonal stimulation for end‐plate jitter studies
30. Stimulation frequency‐dependent neuromuscular junction transmission defects in patients with prior paralytic poliomyelitis
31. Single fiberelectromyography in various processes affecting the anterior horn cell
32. The effects of nerve injury on the neuromuscular junction
33. Miscellaneous neuromuscular transmission disorders
34. Myasthenic syndrome in patients with amyotrophic lateral sclerosis
35. Amyotrophic lateral sclerosis impairment of neuromuscular transmission
36. Motor neuron disease: Decremental response to repetitive nerve stimulation
37. Myasthenic syndrome studies with single‐fiber electromyography
38. Decades after polio epidemics, survivors report new symptoms
39. Treatment of fatigue in the post‐poliomyelitis syndrome with pyridostigmine
40. Simplified scale for rating perceived exertion in patients with coronary artery disease
41. A double‐blind placebo controlled crossover study of pyridostigmine in postpolio fatigue
42. Chronic pyridostigmine bromide administration: Side effects among soldiers working in a desert environment
43. Anti‐cholinesterase responsive neuromuscular junction transmission defects in post‐poliomyelitis fatigue
44. Reliable isokinetic evaluation of neuromuscular fatigue and the effects of pyridostigmine in subjects with post‐poliomyelitis syndrome: A pilot study
45. Dysphagia in patients with the post‐polio syndrome
46. Electrophysiology and electrodiagnosis of the post‐polio motor unit